| 注册
首页|期刊导航|中国动脉硬化杂志|传统中药作为PPAR调节剂在动脉粥样硬化治疗中的应用

传统中药作为PPAR调节剂在动脉粥样硬化治疗中的应用

吴莹 张雪莹 郭守东

中国动脉硬化杂志2025,Vol.33Issue(6):461-468,8.
中国动脉硬化杂志2025,Vol.33Issue(6):461-468,8.DOI:10.20039/j.cnki.1007-3949.2025.06.001

传统中药作为PPAR调节剂在动脉粥样硬化治疗中的应用

Application of traditional Chinese medicine for treatment of atherosclerosis via targe-ting PPAR

吴莹 1张雪莹 1郭守东1

作者信息

  • 1. 山东第二医科大学药学院脂代谢与动脉粥样硬化研究室,山东省 潍坊市 261053
  • 折叠

摘要

Abstract

Atherosclerosis is recognized as an inflammatory disease,and its development is regulated by multiple fac-tors,particularly dyslipidemia.Peroxisome proliferator-activated receptor(PPAR)regulate the expression of genes that are involved in lipid metabolism and inflammation;and they have three subfamily members including PPARα,PPARβ,and PPARγ.However,synthetic PPAR agonists exhibit ambiguous effects in atherosclerotic therapy and induce various side effects.Notably,recent studies demonstrate that traditional Chinese medicine(TCM)alleviate atherosclerotic cardiovascular diseases via suppressing hyperlipidemia and inflammation through regulation of PPAR signaling pathway.This article pri-marily reviews the regulatory effects of TCM on PPAR and their therapeutic effects on atherosclerosis,provides valuable in-formation for pharmacologists that are interested in searching for effective herbal prescriptions for atherosclerosis therapy and for clinicians that are interested in prevention and treatment of atherosclerotic cardiovascular diseases using TCM.

关键词

传统中药/过氧化物酶体增殖物激活受体/脂质稳态/炎症/心血管疾病

Key words

traditional Chinese medicine/peroxisome proliferator-activated receptor/lipid homeostasis/in-flammation/cardiovascular diseases

分类

医药卫生

引用本文复制引用

吴莹,张雪莹,郭守东..传统中药作为PPAR调节剂在动脉粥样硬化治疗中的应用[J].中国动脉硬化杂志,2025,33(6):461-468,8.

基金项目

国家自然科学基金项目(82070469) (82070469)

中国动脉硬化杂志

1007-3949

访问量1
|
下载量0
段落导航相关论文